A defective virus is a viral particle that lacks essential genetic information necessary for successful replication in host cells and therefore requires a helper virus to provide the missing functions.
Explanation and context
In the replication cycle of viruses, each stage is encoded by genes within the viral genome. However, errors during replication or packaging can lead to viral particles missing critical genetic segments or carrying large deletions. These defective viruses cannot complete their life cycle independently. They rely on co-infection with a competent helper virus that supplies missing functions, such as enzymes for genome replication, structural proteins or envelope components. Defective viruses arise naturally in many RNA and DNA virus families and are sometimes called defective interfering particles when they interfere with replication of the helper virus. Because defective genomes replicate more quickly than complete genomes, they can outcompete the wild-type virus for resources, leading to decreased pathogenicity and viral load. In some cases, defective viruses play a role in persistent infections or modulate immune responses. Adeno-associated viruses (AAVs) are naturally defective parvoviruses that integrate into the host genome and require adenovirus or herpesvirus for productive replication; AAVs have been engineered as gene therapy vectors due to their safety and stable integration. Hepatitis D virus, a satellite of hepatitis B virus, encodes its own ribozyme and delta antigen but relies on hepatitis B surface antigen to package new virions. Understanding the biology of defective viruses and defective interfering particles provides insights into viral evolution, host-virus interactions and potential antiviral strategies.
Examples and notable phenomena
Defective interfering particles in influenza viruses arise when segments are deleted from the genome; they compete with full-length genomes and can attenuate infection. Paramyxoviruses often generate defective copyback genomes that stimulate strong interferon responses. Adeno-associated virus depends on adenovirus or herpesvirus to provide functions necessary for replication and packaging, a property exploited in gene therapy vector production. Hepatitis D virus depends on co-infection with hepatitis B virus to acquire an envelope. Helper-dependent adenoviral vectors used in gene therapy lack viral coding regions and require a helper virus for packaging. These examples illustrate how defective viruses can influence disease severity and be harnessed for biomedical applications. Defective viruses underscore the reliance of some viral particles on helper viruses and highlight the dynamic nature of viral genomes. Recognizing these relationships aids in understanding viral pathogenesis and in developing novel antiviral and gene therapy strategies. Related Terms: Helper virus, Defective interfering particle, Hepatitis D virus, Adeno-associated virus, Gene therapy